ASO Visual Abstract: Neoadjuvant Chemotherapy Does Not Improve Survival in cT2N0M0 Gastric Adenocarcinoma Patients-A Multicenter Propensity Score Analysis

被引:0
|
作者
Abboretti, Francesco [1 ,2 ]
Lambert, Celine [3 ]
Schaefer, Markus [1 ,2 ]
Pereira, Bruno [3 ]
Le Roy, Bertrand [4 ]
Mege, Diane [5 ]
Piessen, Guillaume [6 ,7 ]
Gagniere, Johan [8 ,9 ]
Gronnier, Caroline [10 ,11 ]
Mantziari, Styliani [1 ,2 ]
机构
[1] CHU Vaudois, Lausanne Univ Hosp, Dept Visceral Surg, Lausanne, Switzerland
[2] Univ Lausanne UNIL, Fac Biol & Med, Lausanne, Switzerland
[3] CHU Clermont Ferrand, Biostat Unit, DRCI, Clermont Ferrand, France
[4] CHU St Etienne, Hosp Nord, Dept Digest & Oncol Surg, St Priest En Jarez, France
[5] Aix Marseille Univ, Timone Univ Hosp, APHM, Dept Digest Surg, Marseille, France
[6] CHU Lille, Dept Digest & Oncol Surg, Lille, France
[7] Univ Lille, CHU Lille, Canc Heterogene Plast & Resistance Therapies, CNRS,Inserm,UMR9020,U1277,CANTHER, Lille, France
[8] Estaing Univ Hosp, Dept Digest Surg & Liver Transplantat, Clermont Ferrand, France
[9] Clermont Auvergne Univ, Inserm, U1071, Clermont Ferrand, France
[10] Bordeaux Univ Hosp, Magellan Ctr, Dept Digest Surg, Eso Gastr Surg Unit, Pessac, France
[11] Bordeaux Segalen Univ, Fac Med, Bordeaux, France
关键词
D O I
10.1245/s10434-024-15533-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:8193 / 8194
页数:2
相关论文
共 50 条
  • [31] A Multicenter Retrospective Study of Elective Neck Dissection for T1-2N0M0 Tongue Squamous Cell Carcinoma: Analysis Using Propensity Score-Matching
    Mitsunobu Otsuru
    Yoshihide Ota
    Souichi Yanamoto
    Masaya Okura
    Masahiro Umeda
    Tadaaki Kirita
    Hiroshi Kurita
    Michihiro Ueda
    Takahide Komori
    Nobuhiro Yamakawa
    Takahiro Kamata
    Takumi Hasegawa
    Takahiko Shibahara
    Youichi Ohiro
    Yoshihiro Yamashita
    Kazuma Noguchi
    Tadahide Noguchi
    Kazunari Karakida
    Hiroyuki Naito
    Tomonao Aikawa
    Tetsuro Yamashita
    Daijiro Kabata
    Ayumi Shintani
    Annals of Surgical Oncology, 2019, 26 : 555 - 563
  • [32] Differential Analysis of Surgical Treatment Modalities in T2N0M0 Bladder Cancer Patients: A Novel Propensity Score-Based Cohort Study
    Yang, Yu-Xuan
    Ye, Gui-Chen
    Xiang, Jia-Cheng
    Luo, Kuang-Di
    Wang, Shao-Gang
    Xia, Qi-Dong
    CLINICAL GENITOURINARY CANCER, 2025, 23 (01)
  • [33] ASO Visual Abstract: Long-Term Outcomes of Perioperative versus Neoadjuvant Chemotherapy for Resectable Colorectal Liver Metastases-An International Multicenter Propensity-Score Matched Analysis with Stratification by Contemporary Risk Scoring
    Di Martino, Marcello
    Primavesi, Florian
    Syn, Nicholas
    Dorcaratto, Dimitri
    de la Hoz Rodriguez, Angela
    Dupre, Aurelien
    Piardi, Tullio
    Rhaiem, Rami
    Blanco Fernandez, Gerardo
    de Armas Conde, Noelia
    Rodriguez Sanjuan, Juan Carlos
    Fernandez Santiago, Roberto
    Fernandez-Moreno, Maria-Carmen
    Ferret, Georgina
    Lopez Ben, Santiago
    Suarez Munoz, Miguel Angel
    Perez-Alonso, Alejandro J.
    Koh, Ye-Xin
    Jones, Robert
    Martin-Perez, Elena
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (11) : 6845 - 6846
  • [34] Adjuvant chemotherapy and survival outcomes in rectal cancer patients with good response (ypT0-2N0) after neoadjuvant chemoradiotherapy and surgery: A retrospective nationwide analysis
    Kuo, Yu-Hsuan
    Lin, Yun-Tzu
    Ho, Chung-Han
    Chou, Chia-Lin
    Cheng, Li-Chin
    Tsai, Chia-Jen
    Hong, Wei-Ju
    Chen, Yi-Chen
    Yang, Ching-Chieh
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [35] Upfront surgery, neoadjuvant, and definitive chemoradiation for clinical T2N0 esophageal adenocarcinoma: A propensity score matched analysis from the National Cancer Database analysis.
    Shridhar, Ravi
    Huston, Jamie
    Meredith, Kenneth L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [36] Cycle number of neoadjuvant chemotherapy might influence survival of patients with T1-4N2-3M0 nasopharyngeal carcinoma
    Wei, Jiawang
    Feng, Huixia
    Xiao, Weiwei
    Wang, Qiaoxuan
    Qiu, Bo
    Liu, Shiliang
    Deng, Meiling
    Lu, Lixia
    Chang, Hui
    Gao, Yuanhong
    CHINESE JOURNAL OF CANCER RESEARCH, 2018, 30 (01) : 51 - +
  • [37] Survival benefits of postoperative radiotherapy in patients with cT1-2N1M0 breast cancer after neoadjuvant chemotherapy: a SEER-based population study
    Yang, Jie
    Zhao, Jie
    Chang, Hui
    Yan, Lijuan
    Zhang, Jinru
    Liu, Haiming
    Ning, Peng
    BMC WOMENS HEALTH, 2024, 24 (01)
  • [38] Cycle number of neoadjuvant chemotherapy might influence survival of patients with T1-4N2-3M0 nasopharyngeal carcinoma
    Jiawang Wei
    Huixia Feng
    Weiwei Xiao
    Qiaoxuan Wang
    Bo Qiu
    Shiliang Liu
    Meiling Deng
    Lixia Lu
    Hui Chang
    Yuanhong Gao
    ChineseJournalofCancerResearch, 2018, 30 (01) : 51 - 60
  • [39] Comparison of Survival Outcomes of Different Treatment Options for cT1-2, N0 Glottic Carcinoma: A Propensity Score-Weighted Analysis
    Liang, Qi-wei
    Peng, Liang
    Liao, Jing
    Huang, Chun-xia
    Wen, Wei-ping
    Sun, Wei
    FRONTIERS IN SURGERY, 2022, 9
  • [40] Final analysis results from a multicenter clinical study of tislelizumab combined with gemcitabine and cisplatin as neoadjuvant therapy in patients with cT2-T4aN0M0 MIBC.
    Lin, Tianxin
    Li, Kaiwen
    Fan, Jinhai
    Wang, Shaogang
    Yu, Dexin
    Xu, Tao
    Lyu, Jiaju
    Qin, Tao
    Liu, Zheng
    Wu, Kaijie
    Wang, Jinyou
    Wang, Qi
    Min, Jie
    Hu, Zhiquan
    Li, Fan
    Zhang, Zhiqiang
    Yu, Luping
    Ding, Sentai
    Huang, Jian
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)